WHO has released new Guidelines on prevention, diagnosis and treatment of chronic hepatitis B (HBV) infection at the 2024 Asian Pacific Conference for the Study of Liver Disease (APASL) in Kyoto, Japan. These guidelines provide a substantial simplification and expansion of eligibility for treatment to overcome barriers in access to HBV testing and treatment.

At Asian Pacific Digestive Week 2023 (APDW 2023) Queen Sirikit National Convention Centre (QSNCC), Bangkok, Thailand.

Professor SK Lam appearing online on screen, with Professor George Lau accepting the Award on behalf of Professor Shiu Kum Lam from Professor Kent Man Chu representing the Board of Directors of APDWF.

Professor Shui-Kum Lam is conferred the first Asian Pacific Digestive Week Federation (APDWF) Meritorious Award at the APDW 2023. This prestigious recognition acknowledges individuals who have made substantial contributions to the consolidation and expansion of the Asian Pacific Digestive Week. The award specifically commends the significant impact an individual has had on fulfilling the objectives and advancing the work of the APDWF, particularly in the organization of high-caliber APDW meetings, one of the largest gathering of Gastroenterologists and Hepatologists.

廖家傑醫生近日接受大公報記者專訪時，談及自己一路以來與肝病研究共同走過的經歷，希望可以積極推動肝病研究成果的臨床轉化，幫助更多國人擺攤肝病困擾

Outcomes by occurrence of immune-mediated adverse events with tremelimumab plus duralumab in the Phase 3 HIMALAYA study in unresctable hepatocellar carsinoma

Seeking a “CURE” for liver diseases-a thirty years’ journey of a hepatologist